Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Mirapexin pramipexole prolonged release: Phase III data

Data at 18 weeks from a double-blind Phase III trial in 507 patients with advanced

Read the full 154 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE